Firefly BioWorks, Inc. (Cambridge, MA) is an early stage company developing next-generation instruments and molecular diagnostic assays for rapid detection of clinically relevant biomarkers. The company leverages on its proprietary microfabrication method to produce thousands of individually barcoded hydrogel particles, functionalized to simultaneously detect a virtually unlimited array of biomolecules in the same sample. Boston Device is collaborating with Firefly to scale-up particle production to meet industry demand, while maintaining the most stringent quality specifications.